Adding product to your cart
- BRAVECTO has not been shown to be effective for 12-weeks duration in puppies or kittens less than 6 months of age.
- BRAVECTO Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence.
- BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing.
- BRAVECTO Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash.
- BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing.
- For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures.
- BRAVECTO Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions.
- BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing.
- For topical use only. Avoid oral ingestion.The safety of BRAVECTO has not been established in breeding, pregnant, and lactating cats.
- Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO, even in cats without a history of neurologic abnormalities.
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
